Is OPK a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

3,617 people get OPK articles and Market Currents by email alert.

Get email alerts on OPK »

HEADLINES:

OPKO Surpasses 50% Enrollment in First Phase 3 Trial of RayaldyTM (CTAP101 Capsules)

Business Wire (Thu, 9:32AM)
Prolor Biotech Buyout: Is The Opko Bear Case Now Dead?
Daniel Lauchheimer • Wed, May 22 • 5 Comments
OPKO Announces First Quarter 2013 Operating and Financial Highlights

Business Wire (May 9, 2013)
Near-Term Catalysts And High Insider Ownership Make GTx An Attractive Buy
Scott Matusow • Tue, May 7 • 8 Comments
Netupitant Results Could Roil Tesaro In May
Richard Pearson • Mon, May 6 • 9 Comments
Opko Health Leverages Its CEO's Wealth
Kevin Quon • Sun, May 5 • 2 Comments
Opko's Next Acquisition?
Markus Aarnio • Thu, May 2 • 8 Comments
A Sweeter Deal On The Horizon For Prolor Biotech?
Stefan Bordonaro • Wed, May 1 • 29 Comments
Why Document Security Systems Is My Favorite Speculative Play For 2013
Carl Cachia • Sun, Apr 28 • 22 Comments
OPKO Health To Acquire PROLOR Biotech

PR Newswire (Apr 24, 2013)
OPKO Health Acquires Interest in Growing Russian Pharmaceutical Company

Business Wire (Apr 18, 2013)
Bullish Insider Buying Activity Surfacing Among These Names In Real Estate, Healthcare
Insightful Investor • Tue, Apr 16 • 8 Comments
Opko Health: This Biotech Short Bites Back
Josh Ginsburg • Tue, Apr 16 • 12 Comments
Opko Health Is On Its Way To Growth. Buy Before Others Do
Stock Picker • Mon, Apr 15 • 13 Comments
Tesaro's Rolapitant: Investors Pay 17x Premium For Discarded Drug
Apsara Biotechnology Research • Thu, Apr 11 • 10 Comments
Opko's Frost Continues To Prop Up The Company's Shares
Kevin Quon • Thu, Apr 11 • 10 Comments
Valuation Model For Opko Health: $14.88
Robert Mohle • Wed, Apr 10 • 20 Comments
5 Companies With Unusually Large CEO Purchases
Kevin Quon • Tue, Apr 9
Opko: Retail Investors Vs. The Insider Cliff
Richard Pearson • Tue, Apr 9 • 55 Comments
Cramer's Mad Money - 13 Things To Watch In The Week Ahead (4/5/13)
SA Editor Miriam Metzinger • Sun, Apr 7 • 3 Comments

To learn more about Seeking Alpha Pro, click here.

Opko Health Leverages Its CEO's Wealth
Kevin Quon • Sun, May 5 • 2 Comments
Opko's Next Acquisition?
Markus Aarnio • Thu, May 2 • 8 Comments
Opko Health: This Biotech Short Bites Back
Josh Ginsburg • Tue, Apr 16 • 12 Comments
Opko Health Is On Its Way To Growth. Buy Before Others Do
Stock Picker • Mon, Apr 15 • 13 Comments
Opko's Frost Continues To Prop Up The Company's Shares
Kevin Quon • Thu, Apr 11 • 10 Comments
Valuation Model For Opko Health: $14.88
Robert Mohle • Wed, Apr 10 • 20 Comments
Opko: Retail Investors Vs. The Insider Cliff
Richard Pearson • Tue, Apr 9 • 55 Comments
Is Opko Still A Buy As Frost Continues To Purchase Shares?
Kevin Quon • Mon, Mar 11 • 14 Comments
Opko Health's Plate Is Too Full
Zhen Lu • Wed, Feb 27 • 26 Comments
Opko Health, Sell-Off, And Prostate Cancer Test
Robert Mohle • Tue, Feb 12 • 10 Comments
Opko Rises On Frost's Conviction Buy And Management Confidence
Kevin Quon • Mon, Feb 11 • 2 Comments
Dose Of Reality: Opko Set For A Pullback As Insider Selling Begins
Richard Pearson • Fri, Feb 8 • 57 Comments
Opko's Frost Resumes His Purchases
Kevin Quon • Fri, Feb 1 • 7 Comments
Opko Health: A Potential $8.3 Billion A Year Company In The Making
Josh Ginsburg • Thu, Jan 31 • 13 Comments
Opko Health's CEO Stops Buying Company Stock
Kevin Quon • Thu, Jan 31 • 26 Comments
Opko's Billionaire CEO Invests In MusclePharm
John H. Ford • Mon, Jan 28 • 15 Comments
Opko Health: Billionaires, Quantum Physics And The Flux Capacitor
Josh Ginsburg • Thu, Jan 24 • 13 Comments
Opko's Frost: The CEO Who Keeps Buying His Company's Stock
Kevin Quon • Tue, Jan 15 • 13 Comments
Opko's 4KScore Could Generate Over $1.8 Billion Annually
John H. Ford • Wed, Oct 3, 2012 • 23 Comments
Opko Health Continues To Sustain Strong Insider Support
Kevin Quon • Mon, Oct 1, 2012 • 3 Comments

Prolor Biotech Buyout: Is The Opko Bear Case Now Dead?
Daniel Lauchheimer • Wed, May 22 • 5 Comments
Near-Term Catalysts And High Insider Ownership Make GTx An Attractive Buy
Scott Matusow • Tue, May 7 • 8 Comments
Netupitant Results Could Roil Tesaro In May
Richard Pearson • Mon, May 6 • 9 Comments
A Sweeter Deal On The Horizon For Prolor Biotech?
Stefan Bordonaro • Wed, May 1 • 29 Comments
Why Document Security Systems Is My Favorite Speculative Play For 2013
Carl Cachia • Sun, Apr 28 • 22 Comments
Bullish Insider Buying Activity Surfacing Among These Names In Real Estate, Healthcare
Insightful Investor • Tue, Apr 16 • 8 Comments
Tesaro's Rolapitant: Investors Pay 17x Premium For Discarded Drug
Apsara Biotechnology Research • Thu, Apr 11 • 10 Comments
5 Companies With Unusually Large CEO Purchases
Kevin Quon • Tue, Apr 9
Cramer's Mad Money - 13 Things To Watch In The Week Ahead (4/5/13)
SA Editor Miriam Metzinger • Sun, Apr 7 • 3 Comments
Insider Siren: Insiders Are Purchasing These Stocks
Insightful Investor • Thu, Mar 28 • 6 Comments
KKR, Blackstone And Carlyle: Which Is Priced Lowest?
Robert Mohle • Tue, Mar 26 • 5 Comments
Live Performance Of A Momentum-Based Strategy
Sergey Gorshunov • Mon, Mar 18 • 6 Comments
Investors Seeing Huge Potential In RNA Drug Developers
Brian L. Wilson • Fri, Mar 8 • 2 Comments
Are These Insiders Telling Us To Buy These Stocks?
Insightful Investor • Wed, Mar 6 • 9 Comments
5 Companies With Recent CEO Purchases Valued Over $250,000
Kevin Quon • Tue, Feb 26 • 2 Comments
Cramer's Lightning Round - Zoetis Is Better Than The Average IPO (2/20/13)
SA Editor Miriam Metzinger • Thu, Feb 21 • 2 Comments
Rising Stocks And The Wealthy Insiders Buying Them Up
Kevin Quon • Wed, Feb 20 • 4 Comments
Insider Alarm: Are These Stocks Worthy Of Our Portfolio?
Insightful Investor • Mon, Feb 18
Insider Alarm: Should We Follow The Insiders Into These 5 Stocks?
Insightful Investor • Sun, Feb 10 • 3 Comments
Beware Of The Price / Sales Trap II
George Kesarios • Fri, Feb 8 • 14 Comments

There are no Transcripts on OPK.

OPKO Surpasses 50% Enrollment in First Phase 3 Trial of RayaldyTM (CTAP101 Capsules)

Business Wire (Thu, 9:32AM)
Lightning Round: AOL, Pinnacle Foods & More

at CNBC.com (May 14, 2013)
OPKO Announces First Quarter 2013 Operating and Financial Highlights

Business Wire (May 9, 2013)
OPKO Health To Acquire PROLOR Biotech

PR Newswire (Apr 24, 2013)
OPKO Health Acquires Interest in Growing Russian Pharmaceutical Company

Business Wire (Apr 18, 2013)
Cramer: Major Profit Potential in 2 Diagnostics

at CNBC.com (Apr 5, 2013)
OPKO Health Announces Publication of Study Detecting Antibodies in NMO Patients Using OPKO Screening Technology

Business Wire (Apr 5, 2013)
RXi Pharmaceuticals and OPKO Health Announce Strategic Pooling of RNAi Assets

Business Wire (Mar 7, 2013)
RXi Pharmaceuticals Announces $16.4 Million Placement of Common Stock

Business Wire (Mar 7, 2013)
OPKO Health Completes Acquisition of Two Phase 3 Products

Business Wire (Mar 4, 2013)
OPKO Point-of-Care Technology Demonstrated on Mobile Device with Cloud Connectivity to Diagnose and Track Disease in Africa

Business Wire (Mar 1, 2013)
Lightning Round: US Airways, Coach & More

at CNBC.com (Feb 20, 2013)
OPKO Health Completes Acquisition of Brazilian Pharmaceutical Company

Business Wire (Feb 15, 2013)
Clarification Regarding Exercise and Sale of Common Stock Options by OPKO Health Company Officer

Business Wire (Feb 8, 2013)
OPKO Closes Offering of $175 Million of 3.00% Convertible Senior Notes Due 2033

Business Wire (Jan 31, 2013)
OPKO Prices Offering of $175 Million of 3.00% Convertible Senior Notes Due 2033

Business Wire (Jan 25, 2013)
OPKO Announces Proposed Private Offering of $150 Million Convertible Senior Notes Due 2033

Business Wire (Jan 23, 2013)
Lightning Round: SolarCity, Westport Innovations & More

at CNBC.com (Jan 17, 2013)
OPKO Health Expands Collaboration with Bristol-Myers Squibb

Business Wire (Jan 14, 2013)
OPKO Health to Acquire Two Phase 3 Products

Business Wire (Jan 8, 2013)

OPK vs. ETF Alternatives

Company Description

Currently, there's no company description for OPK.

Sector: Healthcare

Industry: Medical Appliances & Equipment

Country: United States

All
| Earnings
| Dividends
| M&A
| On the move

Wednesday, April 24, 9:08 AM Prolor Biotech (PBTH), will be acquired by OPKO Health (OPK) in an all-stock deal worth $480M. PBTH shareholders will get 0.9551 shares of OPK for every share of PBTH they own, equating to $7 per share as of Tuesday's closing prices. PBTH +10.65% premarket. (Previously: strategic alternative evaluation boosts Prolor) 2 Comments [M&A, On the Move]
Thursday, March 7, 8:58 AM RXi Pharmaceuticals (RXII.OB) raises a gross $16.4M in a private placement led by OPKO Health (OPK) and Frost Gamma Investments Trust, which is controlled by Teva Chairman Phillip Frost. RXi issues 113M shares at $0.145 each, the same as yesterday's closing price. The firm will also acquire substantially all of OPKO's RNAi-related assets in exchange for 50M shares, as well as milestone and royalty payments. Comment! [Healthcare]
Friday, February 8, 6:09 PM OPKO Health (OPK -4.7%) finished the day markedly lower, but off its lows after responding to statements regarding the sale of company stock by Adam Logal, it's vice president, chief accounting officer and treasurer. The company notes that no other officer has exercised options or sold any shares of company stock during the last 12 months and that the sale by Logal was done to address pressing family circumstances. No other sales by insiders are being contemplated. 2 Comments [Healthcare]
Tuesday, January 29, 9:10 AM Premarket gainers: KERX +18%. PLXT +10%. VLO +8%. OPK +7%. HES +7%. RPRX +6%. AKS +6%.
Losers: OXF -24%. ANAC -23%. VMW -19%. LXK -6%. RBS -6%. STX -6%. EDU -5%. Comment! [On the Move]
Thursday, January 24, 9:10 AM Premarket gainers: NFLX +39%. SWFT +15%. ERJ +11%. NEWL +9%.
Losers: MLNX -19%. NOK -10%. ESI -10%. AAPL -10%. LOGI -9%. KMT -7%. URRE -6%. CRUS -6%. ALTR -5%. FIO -5%. VRNG -5% . OPK -5% . Comment! [On the Move]
Wednesday, January 23, 5:15 PM OPKO Health (OPK) is down in late trade after announcing a private offering to sell around $150M in convertible senior notes maturing in 2033. The notes will be listed as senior unsecured obligations and will rank equally with all of OPK's existing senior unsecured debt. Shares -6% AH. 4 Comments [Healthcare]
Thursday, December 27, 2012, 1:04 PM Drugmaker and diagnostics firm Opko Health (OPK +0.5%) acquires Brazilian pharmaceutical company Silcon Comercio, Importacao E Exportacao de Produtos Farmaceuticos e Cosmeticos Ltda. The acquisition represents an important strategic move for OPK's diagnostic business. It permits the commercialization of its prostate cancer test in the region while the company obtains local approval to market its point of care microfluidics disposable test cassettes. Comment! [Healthcare, Global & FX, M&A]
Wednesday, August 22, 2012, 3:52 PM Opko Health (OPK +1.6%) has been awarded a NASA contract to implement its Claros-1 point-of-care diagnostic platform for use on the International Space Station. OPK will provide a panel of assays, including Vitamin D for bone metabolism, immune health, and inflammation to be used on its portable analyzer. 1 Comment [Healthcare, On the Move]
Monday, July 16, 2012, 10:12 AM Opko Health (OPK -0.2%) appoints Juan Rodriguez as CFO to replace the retiring Rao Uppaluri. Rodriguez has over 20 years of financial and business leadership experience, over half of which is in life sciences. Most recently, Rodriguez was a consultant to German software firm Cognitec. (PR) Comment! [Healthcare]
Thursday, July 5, 2012, 1:58 PM "There's a bull/bear war brewing over Opko Health (OPK -0.4%)," writes SA author Alberto Savrieno, due to due conflicting opinions over whether billionaire CEO Phillip Frost knows what he's doing in buying shares in the company. Savrieno cites Opko's product pipeline and partnerships as reasons for optimism, but notes that it doesn't have much cash. Comment! [Quick Ideas, Healthcare]
Thursday, December 1, 2011, 9:00 AM Premarket gainers: LAVA +25%. TSPT +17%. AMR +12%. AGO +11%. YHOO +4%. LCC +5%. GMCR +3%. CLWR +3%. ALU +3%. SPIL +3%. OPK +3%.
Losers: STNG -19%. LULU -13%. KSS -7%. IRE -5%. JASO -5%. BCS -3%. Comment! [On the Move]
Friday, November 11, 2011, 7:44 AM Shares of Opko Health (OPK) rack up a 5.7% gain premarket after Jefferies initiates coverage with a Buy rating and $8 price target. Analysts point to the firm's diversified portfolio as a driver for "significant upside opportunities." Comment! [On the Move, Healthcare]
Friday, October 14, 2011, 9:15 AM Premarket gainers: CLWR +10%. GOOG +8%. S +8%. OPK +7%. GLUU +7%. HOV +6%. SWKS +6%. ADBE +5%. BIDU +5%. ERIC +5%. GMCR +5%. ALU +5%. COOL +4%. AMR +4%. RFMD +4%. RENN +4%. SOL +4%. TQNT +4%. HAL +4%. WLT +4%. MT +4%. FCX +4%. SINA +3%. AONE +3%. SIRI +3%. UN +3%. ING +3%. NFLX +3%. MU +3%. F +3%.
Losers: DEPO -24%. NCMI -23%. AVII -4%. MAT -3%. Comment! [On the Move]
Thursday, October 13, 2011, 8:58 AM Opko Health (OPK) announces the acquisition of Claros Diagnostics for an undisclosed amount in a move its CEO says will provide "near-term commercialization possibilities" from the use of the firm's microfluidics technology. Comment! [M&A]
Thursday, August 11, 2011, 10:22 AM If it's true that nobody knows a company better than the people running it, then there's hope that stocks are near the bottom, as insiders at 50 companies bought shares during Aug. 3-9, the most since the five days ended March 9, 2009. Among buyers this week were execs at HUN, WMS, CNA, CNL, NYX, CELG, OPK, KSU, GM, AKS. 1 Comment

Alan Brochstein
$OPK has been pumped on its prostate cancer test, but today's NYT article barely mentions it and not so well http://nyti.ms/11LiEv3
Mar 27, 6:22 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Kyle Spencer
$DVA, $WFC, and $OPK up two days in a row now. Is Berkshire $BRK.A, $BRK.B the one buying?
Mar 26, 9:28 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Stephanie Collins
$OPK looking strong this monring. Loks like some follow through from Friday
Feb 25, 9:57 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Stephanie Collins
$OPK Dr. Frost definitely puts his own money where his mouth is. He has been reporting insider sales in $OPK for months now.
Feb 11, 9:45 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

smokeyRose
$OPK Doing well $RNF is Down The well!!
Jan 17, 12:30 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Jeff Pierce
$OPK - very strong chart. overbought, but one to keep an eye on in the future. pic.twitter.com/qws9MNJ6
Jan 16, 7:25 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

smokeyRose
Okay $OPK !!!!!!
Jan 15, 12:15 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

smokeyRose
Bought $OPK for $5.70 of course it goes Down...Bought $RNF For $41.14 Thats up...Bought $GRX for $89.98 in the Red $4.00 I Like my Buys
Jan 15, 9:56 AM
Reply (4)

• !Report Abuse
View all 4 replies
smokeyRose: Yes $RNF loks like a Keeper. a long keeper! specially with That Nice dividend. unless That was a Fiscal cliff year end type of thing.
Jan 15, 11:27 AM
• !Report Abuse
smokeyRose: Don't count down $OPK...this could be a BIG one me thinks!
Jan 15, 11:32 AM
• !Report Abuse
Add a reply...

140 characters

ZetaKap
7 Low-Debt, Cash-Loaded Small Caps http://bit.ly/MHwlXN $CAVM $FLDM $LRN $OPK $PLT $SHFL $WX @ZetaKap
8/20/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Asif Suria
New Post: Insider Weekends http://bit.ly/Mag8VF Buys: $OPK $SNTA $WSM $LPI $AIR || Sells: $STX $ENSG $MIDD $NOW $EGAS
7/9/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

smokeyRose
Bought $OPK for $5.70 of course it goes Down...Bought $RNF For $41.14 Thats up...Bought $GRX for $89.98 in the Red $4.00 I Like my Buys
Jan 15, 9:56 AM
Reply (4)

• !Report Abuse
View all 4 replies
smokeyRose: Yes $RNF loks like a Keeper. a long keeper! specially with That Nice dividend. unless That was a Fiscal cliff year end type of thing.
Jan 15, 11:27 AM
• !Report Abuse
smokeyRose: Don't count down $OPK...this could be a BIG one me thinks!
Jan 15, 11:32 AM
• !Report Abuse
Add a reply...

140 characters

GolliathNationalBank
SHORT TVIX LONG XIV SPY AAPL DIS WYNN WL PRU MRO MS C BAC CIM AGNC FLR NFLX PPO OPK RUSL NBG ALL QUALITY companies for CHEAP!
11/11/11
Reply (1)

• !Report Abuse
View all 1 replies
madav1138: NFLX LOL OMG WTF
11/22/11
• !Report Abuse
Add a reply...

140 characters

Michael Kudrna
$OPK past seller at 5.38, on the move now $$
11/11/11
Reply (4)

• !Report Abuse
View all 4 replies
Optionstrader7: Fair enough, enjoy the ride. We're in as long as Dr. Frost keeps buying
11/11/11
• !Report Abuse
Michael Kudrna: The ride is negligible for me as of right now, breakouts are not being bought with enthusiasm today, overall market volume terrible
11/11/11
• !Report Abuse
Add a reply...

140 characters

Joshua Hayes
Leading stocks in this rally attempt ALXN CPHD SIMO STAA OPK SURG ESIC CBST. Looking for entries #ALXN #CPHD #SIMO #STAA #OPK #SURG #ESIC
10/20/11
Reply (2)

• !Report Abuse
View all 2 replies
Hypnos7: I understand all these picks -- mid-cap, strong earnings, trending upward with a price support -- except CPHD, CBST.
10/20/11
• !Report Abuse
Hypnos7: Their price support seems to be falling away.
10/20/11
• !Report Abuse
Add a reply...

140 characters

OPK Opko Health Inc

OPK

Opko Health Inc